更年期發熱症治療市場 (各產品類型 (荷爾蒙藥、非荷爾蒙藥) ) - 全球產業分析、規模、構成比、成長率、趨勢及預測:2015-2023年
Menopausal Hot Flashes Market: (By Product Type: Hormonal (Estrogen, Progesterone, and Combination), Non-Hormonal, (Brisdelle, and Other Anti-Depressants) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
|出版商||Transparency Market Research||商品編碼||350565|
|出版日期||內容資訊||英文 86 Pages
|更年期發熱症治療市場 (各產品類型 (荷爾蒙藥、非荷爾蒙藥) ) - 全球產業分析、規模、構成比、成長率、趨勢及預測:2015-2023年 Menopausal Hot Flashes Market: (By Product Type: Hormonal (Estrogen, Progesterone, and Combination), Non-Hormonal, (Brisdelle, and Other Anti-Depressants) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023|
|出版日期: 2015年12月31日||內容資訊: 英文 86 Pages||
本報告以更年期發熱症治療 (Menopausal Hot Flash) 治療的全球市場為焦點，提供2015-2023年的期間的交易規模變化依各產品類型 (產品類型 (荷爾蒙藥:雌激素、孕酮、複合藥)、非荷爾蒙藥:Brisdelle、其他抗憂鬱藥) ) 及地區分類的預測，產業結構，供需趨勢，開發新藥，推動、阻礙因素，機會，競爭環境等分析資訊和主要加入企業簡介彙整。
This report on the menopausal hot flashes market studies the current and future prospects of the treatment across the globe. Hot flashes are common symptoms experience by women in menopause transition. Hot flashes are defined as ephemeral, recurring periods of heat sensation and redness, often associated with sweat and are experienced by about 75% of women in the U.S and Europe at some point before or during the menopause period. These tend to decrease in severity and frequency over a few months to a few years, but sometimes persist into old age.
The menopausal hot flashes market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global menopausal hot flashes drugs market with respect to the segments based on the type of therapy, and their geographic analysis. A detailed qualitative analysis of driving and restraining factors for the market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global menopausal hot flashes market.
Based on therapy type, the menopausal hot flashes market has been segmented into two major categories: hormonal and non-hormonal treatment. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.
Geographically, the global menopausal drugs market has been categorized into four major regions and the key countries in the respective region: North America (U.S., Canada), Europe (U.K., Germany, France, Rest of Europe), Asia Pacific (Japan, Australia, India, China, Rest of Asia Pacific), and Rest of the World (Latin America, Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions.
The report also profiles major players in the global menopausal hot flashes market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Allergan plc, Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Merck & Co. Inc., Novartis International AG, Novo Nordisk, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.